pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 396 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
clindamycin palmitate hydrochloride
Clindamycin Palmitate Hydrochloride (clindamycin palmitate hydrochloride)
Skin And Soft Tissue Infections
Somerset Therapeutics LLC
0 catalysts
Marketed
colistimethate sodium
Colistimethate Sodium (colistimethate sodium)
Lower Respiratory Tract Infections
Xellia Pharmaceuticals USA LLC
0 catalysts
Phase 2
comekibart
comekibart [INN]
Atopic Dermatitis (Atopic Eczema)
Shanghai Mabgeek Biotechnology Co Ltd
0 catalysts
← prev
page 10 of 14
next →
131
Pain89
Neurology1
Marketed
cyproheptadine hydrochloride
Cyproheptadine Hydrochloride (cyproheptadine hydrochloride)
Vasomotor Rhinitis
Boscogen Inc
0 catalysts
Marketed
cysteamine DR
Procysbi (cysteamine)
Nephropathic Cystinosis
Horizon Therapeutics USA Inc
0 catalysts
Phase 2
dactolisib tosylate + everolimus
Respiratory Tract Infections
$ACETAdicet Bio, Inc.
0 catalysts
Marketed
delafloxacin meglumine
Baxdela (delafloxacin meglumine)
Skin And Skin Structure Infections (SSSI) Caused By Bacteria
Melinta Therapeutics LLC
0 catalysts
Marketed
demeclocycline hydrochloride
Demeclocycline Hydrochloride (demeclocycline hydrochloride)
Acne Vulgaris
Epic Pharma LLC
0 catalysts
Marketed
desloratadine
Desloratadine (desloratadine)
Chronic Urticaria
Belcher Pharmaceuticals LLC
0 catalysts
Phase 2
deupirfenidone
Idiopathic Pulmonary Fibrosis
Celea Therapeutics
0 catalysts
Phase 3
dexamethasone sodium phosphate
SEMDEXA (dexamethasone sodium phosphate)
Ataxia-Telangiectasia (Louis-Bar Syndrome)
Glucocorticoid receptor
$QNCXQuince Therapeutics, Inc.
0 catalysts
Marketed
dexchlorpheniramine maleate
RyClora (dexchlorpheniramine maleate)
Angioedema
Carwin Pharmaceutical Sales LLC
0 catalysts
Marketed
dextromethorphan
Elixsure DM (dextromethorphan [INN])
Cough
Moberg Pharma AB
0 catalysts
Marketed
dicloxacillin sodium
Dicloxacillin Sodium (dicloxacillin sodium)
Bacterial Pneumonia
Teva Pharmaceuticals USA Inc
0 catalysts
Marketed
dornase alfa
Pulmozyme (dornase alfa)
Cystic Fibrosis
Genentech Inc
0 catalysts
Marketed
doxapram hydrochloride
Doxapram Hydrochloride (doxapram hydrochloride)
Chronic Obstructive Pulmonary Disease (COPD)
Chartwell Pharmaceuticals LLC
0 catalysts
Marketed
durlobactam sodium + sulbactam sodium
Xacduro (durlobactam sodium + sulbactam sodium)
Hospital Acquired Pneumonia (HAP)
Entasis Therapeutics Holdings Inc
0 catalysts
Marketed
dyclonine
Dyclopro (dyclonine [INN])
Pharyngitis
Septodont Inc
0 catalysts
Phase 2
efdoralprin alfa
efdoralprin alfa [INN]
Alpha-1 Antitrypsin Deficiency (A1AD)
$SNYSanofi
0 catalysts
Phase 2
efzofitimod
efzofitimod [INN]
Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease)
$ATYRaTYR PHARMA INC
0 catalysts
Phase 2
elifactant
Neonatal Respiratory Distress Syndrome
Chiesi Farmaceutici SpA
0 catalysts
Phase 2
enamptcumab
eNamptor
Acute Respiratory Distress Syndrome
Aqualung Therapeutics Corp
0 catalysts
Marketed
ensifentrine
Ohtuvayre (ensifentrine)
Bronchiectasis
Phosphodiesterase 3Phosphodiesterase 4
Verona Pharma Ltd
0 catalysts
Marketed
ertapenem sodium
Ertapenem Sodium (ertapenem sodium)
Community-Acquired Bacterial Pneumonia
Fosun Pharma USA Inc
0 catalysts
Phase 3
florensocatib
Bronchiectasis
Chiesi Farmaceutici SpA
0 catalysts
Marketed
flucytosine
Ancobon (flucytosine)
Cryptococcal Meningitis
Bausch Health US LLC
0 catalysts
Marketed
flunisolide
Flunisolide (flunisolide)
Asthma
Riconpharma LLC
0 catalysts
Marketed
formoterol fumarate
Perforomist (formoterol fumarate)
Chronic Bronchitis
Mylan Specialty LP
0 catalysts
Phase 2
galicaftor
Cystic Fibrosis
Cystic fibrosis transmembrane conductance regulator
$SIONSionna Therapeutics, Inc.
0 catalysts
Phase 2
genistein
Pulmonary Fibrosis
Humanetics Corp
0 catalysts